Therapeutic indications
For the treatment of dogs weighing between 2 and 10 kg, to be used against infestations with fleas, ticks and chewing lice.
Treatment of flea infestations (ctenocephalides spp.).
The insecticidal activity against new adult flea infestations persists for 8 weeks.
Prevents the multiplication of fleas by inhibiting the development of eggs (ovicidal activity), pupae and larvae (larvicidal activity) born from eggs laid by adult fleas, for 8 weeks after application.
Treatment of tick infestations (ixodes ricinus, dermacentor varias, dermacentor reticulatus, rhipicephalus sanguineus).
The product has persistent activity against ticks for up to 4 weeks.
Treatment of biting lice (trichodectes canis) infestations. Frontline combo spot-on for dogs can be used in the program for the control of flea allergic dermatitis (dap).
Dosage and administration
Route of administration: external, for topical skin application.
Dosage: one 0.67 ml pipette for dogs weighing between 2 and 10 kg, corresponding to the minimum recommended dose of 6.7 mg/kg of fipronil and 6 mg/kg of (s)-methoprene, for topical cutaneous application.
In the absence of safety data, the minimum treatment interval must be 4 weeks.
Contraindications
In the absence of data, do not use the product in puppies under 8 weeks of age and/or weighing less than 2 kg. Do not use in sick (e.g. systemic diseases, fever) or convalescent animals.
Do not use in rabbits, as potentially fatal adverse reactions may occur.
In the absence of studies, it is recommended not to use the product in species other than the target one.
This product is intended for dogs only.
Do not use in cats and ferrets, to avoid overdose.
In the absence of safety data, the minimum treatment interval must be 4 weeks.
Excipients
Butylated hydroxyanisole (e320) 0.13 mg, butylated hydroxytoluene (e321) 0.07 mg.
Target species
Dog